GMP-grade mRNA electroporation of dendritic cells for clinical use

Methods in Molecular Biology

Volumn 1428, Issue , 2016, Pages 139-150

  Derdelinckx, Judith ^a   Berneman, Zwi N ^a   Cools, Nathalie ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Cell therapy; Dendritic cells; Electroporation; Good manufacturing practices (GMP); mRNA

Indexed keywords

DENDRITIC CELL VACCINE; MESSENGER RNA;

CELL THERAPY; CONTROLLED STUDY; CRYOPRESERVATION; DENDRITIC CELL; DRUG MANUFACTURE; ELECTROPORATION; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; MONOCYTE; THAWING; BIOLOGICAL THERAPY; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; METABOLISM; PROCEDURES; PROTOCOL COMPLIANCE;

CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; CRYOPRESERVATION; DENDRITIC CELLS; ELECTROPORATION; GUIDELINE ADHERENCE; HUMANS; RNA, MESSENGER;

EID: 84990186301     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-3625-0_9     Document Type: Chapter

References (13)

1. Regulation (EC) No 1394/2007 of the European Parliament and the Council on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No726/2004
2. Directive 2001/83/EC of the European Parliament and of the council of 6 November 2001 on the Community code relating to medicinal products for human use
3. Proposed approach to regulation of cellular and tissue-based products. www.fda.gov/downloads/biologicsBloodVaccines/Guidance/ Tissue/UCM062601.pdf
4. Eaker S, Armant M, Brandwein H, Burger S, Campbell A, Carpenito C, Clarke D, Fong T, Karnieli O, Niss K, Van’t Hof W, Wagey R (2013) Concise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturing. Stem Cells Transl Med 2(11):871-883
5. Van Tendeloo VF, Ponsaerts P, Lardon F, Nijs G, Lenjou M, Van Broeckhoven C, Van Bockstaele DR, Berneman ZN (2001) Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98 (1):49-56
6. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2(1):52-58
7. Van Craenenbroeck AH, Smits EL, Anguille S, Van de Velde A, Stein B, Braeckman T, Van Camp K, Nijs G, Ieven M, Goossens H, Berneman ZN, Van Tendeloo VF, Verpooten GA, Van Damme P, Cools N (2015) Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNAtransfected dendritic cells. Transplantation 99 (1):120-127
8. Van Gulck E, Vlieghe E, Vekemans M, Van Tendeloo VF, Van De Velde A, Smits E, Anguille S, Cools N, Goossens H, Mertens L, De Haes W, Wong J, Florence E, Vanham G, Berneman ZN (2012) mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. AIDS 26(4):F1-F12
9. Van Tendeloo VF, Van de Velde A, Van Driessche A, Cools N, Anguille S, Ladell K, Gostick E, Vermeulen K, Pieters K, Nijs G, Stein B, Smits EL, Schroyens WA, Gadisseur AP, Vrelust I, Jorens PG, Goossens H, de Vries IJ, Price DA, Oji Y, Oka Y, Sugiyama H, Berneman ZN (2010) Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination. Proc Natl Acad Sci U S A 107(31):13824-13829
10. European Commission. EudraLex-Volume 4: Good manufacturing practice (GMP) Guidelines. http://ec.europa.eu/health/documents/eudralex/vol-4/index_en.htm
11. Fratantoni JC, Dzekunov S, Singh V, Liu LN (2003) Anon-viral gene delivery system designed for clinical use. Cytotherapy 5(3):208-210
12. Cools N, Van Camp K, Van Tendeloo V, Berneman Z (2013) mRNA electroporation as a tool for immunomonitoring. Methods Mol Biol 969:293-303
13. Smits EL, Stein B, Nijs G, Lion E, Van Tendeloo VF, Willemen Y, Anguille S, Berneman ZN (2016) Generation and cryopreservation of clinical grade Wilms’ tumor 1 mRNA-loaded dendritic cell vaccines for cancer immunotherapy. Methods Mol Biol 1393:27-35